A new study on the global Cancer Vaccine Platforms Market confirms a period of explosive growth, driven by unprecedented technological advancements in immunotherapy. The market, which was valued at USD 3.46 billion in 2024, is projected to soar to USD 10.59 billion by 2032. This substantial expansion represents a Compound Annual Growth Rate (CAGR) of 15.00% during the forecast period ...